Cost, Value, and Growth: What CFOs Are Watching in 2025

Revenue cycle performance begins before a claim is produced. Measure scheduling accuracy, insurance verification, authorization, medical necessity documentation, coding, charge capture, claim acceptance, denial root cause, appeal yield, payment variance, credit balance, and cash posting. Segment performance by payer, service line, site, and denial category so corrective action reaches the actual failure point.

Distinguish gross revenue activity from realizable cash. CFOs should understand contractual allowances, underpayments, aged accounts, disputed claims, bad-debt assumptions, charity care, and payer behavior. Monitor days in accounts receivable alongside the distribution and collectability of balances. A stable average can conceal a growing group of old or high-risk accounts.

Treat hospital price transparency and patient estimates as operating capabilities, not a web-publishing exercise. Charges, negotiated rates, shoppable-service information, estimates, financial-assistance screening, statements, and contact-center answers should be consistent enough to support patient decisions. Compliance, finance, revenue cycle, managed care, technology, and communications all own part of that experience.

Strengthen payer-contract governance. Maintain a controlled inventory of terms, amendments, fee schedules, quality provisions, timely filing rules, authorization requirements, stop-loss arrangements, and dispute rights. Model contracts before signature, load them accurately, test actual payments, and pursue variances. For value-based agreements, identify attributed populations, data latency, benchmark methodology, risk corridors, quality gates, settlement timing, and downside exposure.

Affordability must remain visible. Track out-of-pocket estimates, financial-assistance applications, approval time, payment-plan performance, complaints, and avoidable collection friction. Revenue integrity and patient trust can reinforce each other when information is accurate, assistance is accessible, and escalation is humane.

Value-based performance requires patient-level operating ownership. Translate contract incentives into actions around prevention, chronic care, leakage, medication, documentation, post-acute transitions, readmissions, avoidable utilization, and site of care. Finance should reconcile contract definitions and settlements, while clinical and population-health teams manage the care pathways that produce results.

Do not aggregate all value-based contracts into one result. Contract populations, benchmarks, attribution rules, risk adjustment, quality gates, shared-savings formulas, stop-loss provisions, and data timing differ. Maintain a contract-level forecast with range, confidence, leading clinical measures, and cash timing. Reserve or accrual judgments should be controlled and transparent.

Apply the same discipline to technology and artificial intelligence. A proposal should identify the problem, affected workflow, safety and privacy controls, integration, implementation cost, cybersecurity, vendor dependency, adoption plan, expected benefit, and measurement method. Automation may reduce touches or delay, but it may also shift work, generate exceptions, or require new oversight.

Create an enterprise benefit-realization register for major transformation work. Record the approved baseline, investment, recurring cost, owner, milestone, operational change, expected quality or access effect, financial effect, and evidence. Finance should prevent double counting when several initiatives claim the same capacity, labor, or revenue benefit.

Give the board an integrated portfolio view. Show where margin is generated, which services require mission support, what risks are rising, how much capital is committed, which returns have been verified, and what management wants to stop, scale, or redesign. Strategic finance is credible when leaders disclose uncertainty and act before a forecast miss becomes a liquidity problem.